Pediatrics

FDA approves Verkazia for treatment of vernal keratoconjunctivitis

Jun 24, 2021

The U.S. Food and Drug Administration has approved Verkazia (cyclosporine ophthalmic emulsion; Santen Inc) 0.1% eye drops for the treatment of vernal keratoconjunctivitis (VKC) in children and adults, according to a press release.

“This is an important milestone in Santen’s aim to bring innovative solutions that protect vision for those affected by rare ophthalmic conditions, and is the first prescription product approval for Santen in the U.S. market,” said Tatsuya…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Videos

Jan 14, 2019
Atropine for Myopia: Latest Outcomes
Jan 02, 2019
Don’t Duck the Tuck
Dec 26, 2018
Introduction to Amblyopia Vision Screening…
Dec 17, 2018
What Did You Do to My Baby? A Ptosis Surgery Saga

View All

Conference Roundup

Apr 13, 2021

Most ophthalmologists think AI will improve ophthalmology

Most ophthalmologists have positive opinions on the concept and potential impact of artificial intelligence (AI) in ophthalmology, although some worry about its diagnostic accuracy, according to survey results presented at the 2021 Virtual AAPOS Meeting. …

Mental health of eye care professionals impacted by COVID-19
Apr 13, 2021
Pediatric ophthalmology takes center stage at AAPOS 2021 Virtual Meeting
Apr 02, 2021
Study Explores Management Options for Children With Clinically Suspected Keratoconus
May 23, 2019
Why Instrument-Based Screening for Amblyopia?
Mar 26, 2019

View All

Journal Scan

Jun 10, 2021

Long-term use of tacrolimus ointment safe in kids with refractory ocular surface inflammation

Long-term use of topical tacrolimus 0.02% ointment is safe and effective in pediatric patients with refractory ocular surface inflammation, according to a study.

In this retrospective study, a…